BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
Open Access
- 16 January 2013
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Journal of Neuroinflammation
- Vol. 10 (1), 10
- https://doi.org/10.1186/1742-2094-10-10
Abstract
B-cell dysregulation has been implicated but not fully characterized in pediatric opsoclonus-myoclonus syndrome (OMS), a neuroblastoma-associated neuroinflammatory disorder.Keywords
This publication has 30 references indexed in Scilit:
- Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus SyndromeJournal of Child Neurology, 2012
- Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMSJournal of Neuroimmunology, 2012
- Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and diseaseImmunological Reviews, 2011
- Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritisArthritis & Rheumatism, 2011
- BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphomaThe Journal of Experimental Medicine, 2005
- Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2004
- B Cell-Activating Factor Belonging to the TNF Family (BAFF)-R Is the Principal BAFF Receptor Facilitating BAFF Costimulation of Circulating T and B CellsPublished by The American Association of Immunologists ,2004
- CSF B‐cell expansion in opsoclonus‐myoclonus syndrome: A biomarker of disease activityMovement Disorders, 2004
- Flow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytesMethods, 2003
- BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell GrowthThe Journal of Experimental Medicine, 1999